| Elizabeth Vang, RPH | |
|
3605 Round Lake Blvd Nw, Anoka, MN 55303-5003 | |
| (763) 252-0751 | |
| Not Available |
| Full Name | Elizabeth Vang |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3605 Round Lake Blvd Nw, Anoka, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780272054 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 123679 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Vang, RPH 3605 Round Lake Blvd Nw, Anoka, MN 55303-5003 Ph: (763) 252-0751 | Elizabeth Vang, RPH 3605 Round Lake Blvd Nw, Anoka, MN 55303-5003 Ph: (763) 252-0751 |
News Archive
More than $18 million in grants to spur the development of a third generation of DNA sequencing technologies was announced today by the National Human Genome Research Institute (NHGRI). The new technologies will sequence a person's DNA quickly and cost-effectively so it routinely can be used by biomedical researchers and health care workers to improve the prevention, diagnosis and treatment of human disease.
A research team led by University of South Florida neuroscientist Huntington Potter, PhD, CEO of the Johnnie B. Byrd Sr. Alzheimer's Center & Research Institute, for the first time has defined how the protein Apolipoprotein E (ApoE) contributes to both the formation of amyloid brain lesions and the memory loss associated with Alzheimer's disease.
OSI Pharmaceuticals, Inc., Genentech, Inc., and Roche today announced that a Phase III study of Tarceva™ (erlotinib HCl), an investigational HER1/EGFR-inhibitor agent in previously treated patients with non-small cell lung cancer (NSCLC), met its primary endpoint of improving overall survival, with patients receiving Tarceva™ living longer than those in the placebo arm of the study.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has announced two awards for the study of influenza immunity in children.
People with Parkinson's disease who show signs of depression may actually have a condition called demoralization, according to a study published in the April 4, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology. That study found demoralization may be common in Parkinson's disease.
› Verified 3 days ago
Alexi Johnson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1911 S Ferry St, Anoka, MN 55303 Phone: 763-576-0388 | |
Carisa Lynn Finke, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3301 7th Ave, Anoka, MN 55303 Phone: 651-431-5123 | |
Dr. Heidi Lee Holthus, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3605 Round Lake Blvd Nw, Anoka, MN 55303 Phone: 763-252-0751 | |
Amanda Marie Schroepfer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 601 Jacob Ln, Anoka, MN 55303 Phone: 763-421-5540 Fax: 763-421-9229 | |
Gordon A. Seim, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1100 W Highway 10, Anoka, MN 55303 Phone: 763-427-7699 Fax: 763-712-8314 | |
Emily K Hulke, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 601 Jacob Ln, Anoka, MN 55303 Phone: 763-421-5540 | |
Steven Thomas Simenson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Monroe St, Anoka, MN 55303 Phone: 763-421-5540 Fax: 763-421-9229 |